cloudfront
  • info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) | +1-214-736-7666 (US) | +1-740-994-0111 (US)
  • Sign In
  • Register

Report Detail



Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Instruments
2.1.1.1. Secondary Instrument
2.1.1.2. Primary Instrument
2.1.2. Research Approaches
2.1.2.1. Bottom-up Approach
2.1.2.2. Top-down Approach
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.1.5. Vendor Inclusion Criteria
2.2. Forecasting Methodology
2.2.1. Methodology for Market Estimation & Forecasting
2.2.2. Significance and Importance of the Market Estimation & Forecasting
3. Executive Summary
3.1. Market Snapshot
3.2. Market Dynamics
3.3. Competitive Analysis
4. Premium Insight
4.1. Market Connectivity
4.2. Market Data Feed
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Increasing research and development activity and funding
4.3.1.2. Increasing focus in Stem Cell and Neurobiology Research
4.3.1.3. Collaborations between industry and academics
4.3.2. Restraints
4.3.2.1. Time and cost consuming antibody development processes
4.3.3. Opportunities
4.3.3.1. Biomarker Discovery gaining attractive market edge
4.3.3.2. Increasing demand for Protein Therapeutics and Personalized Medicine
4.3.3.3. Growth prospects in emerging markets
4.3.4. Challenges
4.3.4.1. Quality concerns
4.3.4.2. Pricing pressure
4.4. Porter’s Five Forces Analysis
4.4.1. Threat of New Entrants
4.4.2. Threat of Substitutes
4.4.3. Bargaining Power of Customers
4.4.4. Bargaining Power of Suppliers
4.4.5. Industry Rivalry
5. Global Research Antibodies Market, by Function
5.1. Immunology
5.1.1. Overview
5.1.2. Market Sizing & Forecasting
5.2. Infectious Diseases
5.2.1. Overview
5.2.2. Market Sizing & Forecasting
5.3. Neurobiology
5.3.1. Overview
5.3.2. Market Sizing & Forecasting
5.4. Oncology
5.4.1. Overview
5.4.2. Market Sizing & Forecasting
5.5. Stem Cells
5.5.1. Overview
5.5.2. Market Sizing & Forecasting
6. Global Research Antibodies Market, by Operation
6.1. Drug Development
6.1.1. Overview
6.1.2. Market Sizing & Forecasting
6.2. Genomics
6.2.1. Overview
6.2.2. Market Sizing & Forecasting
6.3. Proteomics
6.3.1. Overview
6.3.2. Market Sizing & Forecasting
7. Global Research Antibodies Market, by Product
7.1. Monoclonal Antibodies
7.1.1. Overview
7.1.2. Market Sizing & Forecasting
7.2. Polyclonal Antibodies
7.2.1. Overview
7.2.2. Market Sizing & Forecasting
8. Global Research Antibodies Market, by Source
8.1. Goat
8.1.1. Overview
8.1.2. Market Sizing & Forecasting
8.2. Mouse
8.2.1. Overview
8.2.2. Market Sizing & Forecasting
8.3. Rabbit
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
9. Global Research Antibodies Market, by Technology
9.1. Enzyme-linked Immunosorbent Assay
9.1.1. Overview
9.1.2. Market Sizing & Forecasting
9.2. Flow Cytometry
9.2.1. Overview
9.2.2. Market Sizing & Forecasting
9.3. Immunofluorescence
9.3.1. Overview
9.3.2. Market Sizing & Forecasting
9.4. Immunohistochemistry
9.4.1. Overview
9.4.2. Market Sizing & Forecasting
9.5. Immunoprecipitation
9.5.1. Overview
9.5.2. Market Sizing & Forecasting
9.6. Western Blotting
9.6.1. Overview
9.6.2. Market Sizing & Forecasting
10. Global Research Antibodies Market, by Type
10.1. Primary Antibodies
10.1.1. Overview
10.1.2. Market Sizing & Forecasting
10.2. Secondary Antibodies
10.2.1. Overview
10.2.2. Market Sizing & Forecasting
11. Global Research Antibodies Market, by End User
11.1. Academic & Research Institutes
11.1.1. Overview
11.1.2. Market Sizing & Forecasting
11.2. Pharmaceutical & Biotechnology Companies
11.2.1. Overview
11.2.2. Market Sizing & Forecasting
12. Global Research Antibodies Market, by Geography
12.1. Americas
12.1.1. Overview
12.1.2. Market Sizing & Forecasting
12.1.3. United States
12.2. Europe, Middle East & Africa
12.2.1. Overview
12.2.2. Market Sizing & Forecasting
12.2.3. United Kingdom
12.2.4. Germany
12.2.5. Saudi Arabia
12.3. Asia-Pacific
12.3.1. Overview
12.3.2. Market Sizing & Forecasting
12.3.3. China
12.3.4. Japan
12.3.5. India
13. 360iResearch FPNV Positioning Matrix
13.1. 360iResearch Scores
13.1.1. Forefront
13.1.2. Pathfinders
13.1.3. Niche
13.1.4. Vital
13.2. Business Strategy
13.3. Product Satisfaction
14. Competitive News Feed Analysis
15. Company Usability Profiles
15.1. Abcam PLC
15.1.1. Business Overview
15.1.2. Business Strategy
15.1.3. Business SWOT Analysis
15.2. Agilent Technologies, Inc.
15.2.1. Business Overview
15.2.2. Business Strategy
15.2.3. Business SWOT Analysis
15.3. Becton, Dickinson and Company
15.3.1. Business Overview
15.3.2. Business Strategy
15.3.3. Business SWOT Analysis
15.4. Bio-Rad Laboratories, Inc.
15.4.1. Business Overview
15.4.2. Business Strategy
15.4.3. Business SWOT Analysis
15.5. Biolegend, Inc.
15.5.1. Business Overview
15.5.2. Business Strategy
15.5.3. Business SWOT Analysis
15.6. Cell Signaling Technology, Inc.
15.6.1. Business Overview
15.6.2. Business Strategy
15.6.3. Business SWOT Analysis
15.7. Danaher Corporation
15.7.1. Business Overview
15.7.2. Business Strategy
15.7.3. Business SWOT Analysis
15.8. F. Hoffmann-La Roche AG
15.8.1. Business Overview
15.8.2. Business Strategy
15.8.3. Business SWOT Analysis
15.9. GenScript Corporation
15.9.1. Business Overview
15.9.2. Business Strategy
15.9.3. Business SWOT Analysis
15.10. Lonza Group
15.10.1. Business Overview
15.10.2. Business Strategy
15.10.3. Business SWOT Analysis
15.11. Merck Group
15.11.1. Business Overview
15.11.2. Business Strategy
15.11.3. Business SWOT Analysis
15.12. Perkin Elmer, Inc.
15.12.1. Business Overview
15.12.2. Business Strategy
15.12.3. Business SWOT Analysis
15.13. QIAGEN, Inc.
15.13.1. Business Overview
15.13.2. Business Strategy
15.13.3. Business SWOT Analysis
15.14. Sysmex Corporation
15.14.1. Business Overview
15.14.2. Business Strategy
15.14.3. Business SWOT Analysis
15.15. Thermo Fisher Scientific, Inc.
15.15.1. Business Overview
15.15.2. Business Strategy
15.15.3. Business SWOT Analysis
16. Appendix
16.1. Top Reports
16.2. Author Details

LIST OF TABLES (78 TABLES)

TABLE 1. GLOBAL RESEARCH ANTIBODIES MARKET RANKING, BY KEY PLAYER, 2017
TABLE 2. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 3. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 4. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY FUNCTION, 2016 - 2024 (USD MILLION)
TABLE 5. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2016 - 2024 (USD MILLION)
TABLE 6. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 7. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2016 - 2024 (USD MILLION)
TABLE 8. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD MILLION)
TABLE 9. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)
TABLE 10. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2016 - 2024 (USD MILLION)
TABLE 11. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 12. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 13. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY NEUROBIOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 14. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 15. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY STEM CELLS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 16. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY DRUG DEVELOPMENT, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 17. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GENOMICS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 18. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PROTEOMICS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 19. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 20. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 21. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GOAT, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 22. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MOUSE, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 23. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY RABBIT, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 24. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 25. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY FLOW CYTOMETRY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 26. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOFLUORESCENCE, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 27. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 28. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOPRECIPITATION, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 29. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY WESTERN BLOTTING, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 30. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRIMARY ANTIBODIES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 31. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SECONDARY ANTIBODIES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 32. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 33. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 34. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 35. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY FUNCTION, 2016 - 2024 (USD MILLION)
TABLE 36. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2016 - 2024 (USD MILLION)
TABLE 37. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 38. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2016 - 2024 (USD MILLION)
TABLE 39. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD MILLION)
TABLE 40. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)
TABLE 41. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2016 - 2024 (USD MILLION)
TABLE 42. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 43. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY FUNCTION, 2016 - 2024 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2016 - 2024 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2016 - 2024 (USD MILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2016 - 2024 (USD MILLION)
TABLE 50. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 51. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY FUNCTION, 2016 - 2024 (USD MILLION)
TABLE 52. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2016 - 2024 (USD MILLION)
TABLE 53. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 54. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2016 - 2024 (USD MILLION)
TABLE 55. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD MILLION)
TABLE 56. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)
TABLE 57. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2016 - 2024 (USD MILLION)
TABLE 58. 360IRESEARCH SCORES FOR FOREFRONT IN RESEARCH ANTIBODIES MARKET
TABLE 59. 360IRESEARCH SCORES FOR PATHFINDERS IN RESEARCH ANTIBODIES MARKET
TABLE 60. 360IRESEARCH SCORES FOR NICHE IN RESEARCH ANTIBODIES MARKET
TABLE 61. 360IRESEARCH SCORES FOR VITAL IN RESEARCH ANTIBODIES MARKET
TABLE 62. 360IRESEARCH FPNV POSITIONING MATRIX BUSINESS STRATEGY FOR RESEARCH ANTIBODIES MARKET
TABLE 63. 360IRESEARCH FPNV POSITIONING MATRIX PRODUCT SATISFACTION FOR RESEARCH ANTIBODIES MARKET
TABLE 64. COMPETITIVE NEWS FEED ANALYSIS FOR ABCAM PLC IN RESEARCH ANTIBODIES MARKET
TABLE 65. COMPETITIVE NEWS FEED ANALYSIS FOR AGILENT TECHNOLOGIES, INC. IN RESEARCH ANTIBODIES MARKET
TABLE 66. COMPETITIVE NEWS FEED ANALYSIS FOR BECTON, DICKINSON AND COMPANY IN RESEARCH ANTIBODIES MARKET
TABLE 67. COMPETITIVE NEWS FEED ANALYSIS FOR BIO-RAD LABORATORIES, INC. IN RESEARCH ANTIBODIES MARKET
TABLE 68. COMPETITIVE NEWS FEED ANALYSIS FOR BIOLEGEND, INC. IN RESEARCH ANTIBODIES MARKET
TABLE 69. COMPETITIVE NEWS FEED ANALYSIS FOR CELL SIGNALING TECHNOLOGY, INC. IN RESEARCH ANTIBODIES MARKET
TABLE 70. COMPETITIVE NEWS FEED ANALYSIS FOR DANAHER CORPORATION IN RESEARCH ANTIBODIES MARKET
TABLE 71. COMPETITIVE NEWS FEED ANALYSIS FOR F. HOFFMANN-LA ROCHE AG IN RESEARCH ANTIBODIES MARKET
TABLE 72. COMPETITIVE NEWS FEED ANALYSIS FOR GENSCRIPT CORPORATION IN RESEARCH ANTIBODIES MARKET
TABLE 73. COMPETITIVE NEWS FEED ANALYSIS FOR LONZA GROUP IN RESEARCH ANTIBODIES MARKET
TABLE 74. COMPETITIVE NEWS FEED ANALYSIS FOR MERCK GROUP IN RESEARCH ANTIBODIES MARKET
TABLE 75. COMPETITIVE NEWS FEED ANALYSIS FOR PERKIN ELMER, INC. IN RESEARCH ANTIBODIES MARKET
TABLE 76. COMPETITIVE NEWS FEED ANALYSIS FOR QIAGEN, INC. IN RESEARCH ANTIBODIES MARKET
TABLE 77. COMPETITIVE NEWS FEED ANALYSIS FOR SYSMEX CORPORATION IN RESEARCH ANTIBODIES MARKET
TABLE 78. COMPETITIVE NEWS FEED ANALYSIS FOR THERMO FISHER SCIENTIFIC, INC. IN RESEARCH ANTIBODIES MARKET

LIST OF FIGURES (96 TABLES)

FIGURE 1. GLOBAL RESEARCH ANTIBODIES MARKET: YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL RESEARCH ANTIBODIES MARKET: KEY RESEARCH METHODOLOGY
FIGURE 3. GLOBAL RESEARCH ANTIBODIES MARKET: KEY RESEARCH INSTRUMENTS
FIGURE 4. GLOBAL RESEARCH ANTIBODIES MARKET: KEY SECONDARY INSTRUMENT SOURCES
FIGURE 5. GLOBAL RESEARCH ANTIBODIES MARKET: KEY POTENTIAL RESPONDENTS
FIGURE 6. GLOBAL RESEARCH ANTIBODIES MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT
FIGURE 7. GLOBAL RESEARCH ANTIBODIES MARKET: KEY RESEARCH APPROACHES
FIGURE 8. GLOBAL RESEARCH ANTIBODIES MARKET: KEY DATA TRIANGULATION
FIGURE 9. GLOBAL RESEARCH ANTIBODIES MARKET: KEY RESEARCH ASSUMPTIONS
FIGURE 10. RESEARCH ANTIBODIES MARKET: KEY MARKET CONNECTIVITY
FIGURE 11. GLOBAL RESEARCH ANTIBODIES MARKET SHARE, BY GEOGRAPHY, 2017 (%)
FIGURE 12. GLOBAL RESEARCH ANTIBODIES MARKET SHARE, BY FUNCTION, 2017 (%)
FIGURE 13. GLOBAL RESEARCH ANTIBODIES MARKET SHARE, BY OPERATION, 2017 (%)
FIGURE 14. GLOBAL RESEARCH ANTIBODIES MARKET SHARE, BY PRODUCT, 2017 (%)
FIGURE 15. GLOBAL RESEARCH ANTIBODIES MARKET SHARE, BY SOURCE, 2017 (%)
FIGURE 16. GLOBAL RESEARCH ANTIBODIES MARKET SHARE, BY TECHNOLOGY, 2017 (%)
FIGURE 17. GLOBAL RESEARCH ANTIBODIES MARKET SHARE, BY TYPE, 2017 (%)
FIGURE 18. GLOBAL RESEARCH ANTIBODIES MARKET SHARE, BY END USER, 2017 (%)
FIGURE 19. GLOBAL RESEARCH ANTIBODIES MARKET: KEY MARKET DYNAMICS
FIGURE 20. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, 2016 - 2024 (USD MILLION)
FIGURE 21. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 22. GLOBAL RESEARCH ANTIBODIES MARKET OPPORTUNITY ANALYSIS, BY GEOGRAPHY, 2024 (USD MILLION)
FIGURE 23. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY FUNCTION, 2017 (USD MILLION)
FIGURE 24. GLOBAL RESEARCH ANTIBODIES MARKET OPPORTUNITY ANALYSIS, BY FUNCTION, 2024 (USD MILLION)
FIGURE 25. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2017 (USD MILLION)
FIGURE 26. GLOBAL RESEARCH ANTIBODIES MARKET OPPORTUNITY ANALYSIS, BY OPERATION, 2024 (USD MILLION)
FIGURE 27. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2017 (USD MILLION)
FIGURE 28. GLOBAL RESEARCH ANTIBODIES MARKET OPPORTUNITY ANALYSIS, BY PRODUCT, 2024 (USD MILLION)
FIGURE 29. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2017 (USD MILLION)
FIGURE 30. GLOBAL RESEARCH ANTIBODIES MARKET OPPORTUNITY ANALYSIS, BY SOURCE, 2024 (USD MILLION)
FIGURE 31. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2017 (USD MILLION)
FIGURE 32. GLOBAL RESEARCH ANTIBODIES MARKET OPPORTUNITY ANALYSIS, BY TECHNOLOGY, 2024 (USD MILLION)
FIGURE 33. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2017 (USD MILLION)
FIGURE 34. GLOBAL RESEARCH ANTIBODIES MARKET OPPORTUNITY ANALYSIS, BY TYPE, 2024 (USD MILLION)
FIGURE 35. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2017 (USD MILLION)
FIGURE 36. GLOBAL RESEARCH ANTIBODIES MARKET OPPORTUNITY ANALYSIS, BY END USER, 2024 (USD MILLION)
FIGURE 37. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOLOGY, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 38. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 39. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 40. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 41. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY NEUROBIOLOGY, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 42. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY NEUROBIOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 43. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 44. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 45. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY STEM CELLS, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 46. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY STEM CELLS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 47. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY DRUG DEVELOPMENT, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 48. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY DRUG DEVELOPMENT, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 49. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GENOMICS, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 50. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GENOMICS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 51. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PROTEOMICS, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 52. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PROTEOMICS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 53. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 54. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 55. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 56. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 57. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GOAT, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 58. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GOAT, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 59. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MOUSE, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 60. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MOUSE, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 61. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY RABBIT, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 62. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY RABBIT, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 63. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 64. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 65. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY FLOW CYTOMETRY, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 66. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY FLOW CYTOMETRY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 67. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOFLUORESCENCE, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 68. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOFLUORESCENCE, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 69. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 70. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 71. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOPRECIPITATION, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 72. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOPRECIPITATION, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 73. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY WESTERN BLOTTING, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 74. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY WESTERN BLOTTING, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 75. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRIMARY ANTIBODIES, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 76. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRIMARY ANTIBODIES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 77. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SECONDARY ANTIBODIES, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 78. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SECONDARY ANTIBODIES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 79. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 80. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 81. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 82. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 83. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 84. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, 2017 VS 2024 (USD MILLION)
FIGURE 85. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 86. UNITED KINGDOM RESEARCH ANTIBODIES MARKET SIZE, 2017 VS 2024 (USD MILLION)
FIGURE 87. GERMANY RESEARCH ANTIBODIES MARKET SIZE, 2017 VS 2024 (USD MILLION)
FIGURE 88. SAUDI ARABIA RESEARCH ANTIBODIES MARKET SIZE, 2017 VS 2024 (USD MILLION)
FIGURE 89. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 90. CHINA RESEARCH ANTIBODIES MARKET SIZE, 2017 VS 2024 (USD MILLION)
FIGURE 91. JAPAN RESEARCH ANTIBODIES MARKET SIZE, 2017 VS 2024 (USD MILLION)
FIGURE 92. INDIA RESEARCH ANTIBODIES MARKET SIZE, 2017 VS 2024 (USD MILLION)
FIGURE 93. 360IRESEARCH FPNV POSITIONING MATRIX FOR RESEARCH ANTIBODIES MARKET
FIGURE 94. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL RESEARCH ANTIBODIES MARKET, BY NEWS TYPE
FIGURE 95. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL RESEARCH ANTIBODIES MARKET, BY COMPANY
FIGURE 96. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL RESEARCH ANTIBODIES MARKET, BY YEAR

“Increasing research and development activity and funding is one of the factors largely attributing to the growth of research antibodies market globally”

The global research antibodies market is expected to grow from USD 88,721.57 million 2017 to USD 131,831.57 million by the end of 2024, at a Compound Annual Growth Rate (CAGR) of 5.82%.

Market Segmentation & Coverage: The report on global research antibodies market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the economies and geographies of the potential customer group can help to gain business acumen for better strategic decision making. Our market coverage across different industry verticals reveals the hidden truth about the strategies adopted by the players in different verticals and help the organization to decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.This research report categorizes the global research antibodies market to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Function
1. Immunology
2. Infectious Diseases
3. Neurobiology
4. Oncology
5. Stem Cells

Based on Operation
1. Drug Development
2. Genomics
3. Proteomics

Based on Product
1. Monoclonal Antibodies
2. Polyclonal Antibodies

Based on Source
1. Goat
2. Mouse
3. Rabbit

Based on Technology
1. Enzyme-linked Immunosorbent Assay
2. Flow Cytometry
3. Immunofluorescence
4. Immunohistochemistry
5. Immunoprecipitation
6. Western Blotting

Based on Type
1. Primary Antibodies
2. Secondary Antibodies

Based on End User
1. Academic & Research Institutes
2. Pharmaceutical & Biotechnology Companies

Based on Geography
1. Americas (United States)
2. Europe, Middle East & Africa (United Kingdom, Germany, and Saudi Arabia)
3. Asia-Pacific (China, Japan, and India)

Company Usability Profiles:
The research antibodies market research report provides the company usability profiles and analyze the business overview, business product offering, SWOT analysis, and business strategy of the following company:
1. Abcam PLC
2. Agilent Technologies, Inc.
3. Becton, Dickinson and Company
4. Bio-Rad Laboratories, Inc.
5. Biolegend, Inc.
6. Cell Signaling Technology, Inc.
7. Danaher Corporation
8. F. Hoffmann-La Roche AG
9. GenScript Corporation
10. Lonza Group
11. Merck Group
12. Perkin Elmer, Inc.
13. QIAGEN, Inc.
14. Sysmex Corporation
15. Thermo Fisher Scientific, Inc.

Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.

Reasons to Buy:
1. To comprehensively understand of the research antibodies market with respect to major influencing factor such as drivers, restraints, opportunities and challenges
2. To strategically analyze each vertical and geographic sub-segment in the research antibodies market and its individual growth and its impact towards the growth of overall market
3. To position selected vendors in 360iResearch FPNV Positioning Matrix for the research antibodies market to uncover a competitive landscape based on business strategy and product satisfaction




Summary:
Get latest Market Research Reports on Research Antibodies Market . Industry analysis & Market Report on Research Antibodies Market is a syndicated market report, published as The global research antibodies market is expected to grow from USD 88,721.57 million 2017 to USD 131,831.57 million by the end of 2024, at a CAGR of 5.82%.. It is complete Research Study and Industry Analysis of Research Antibodies Market market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$2,999.00
$3,999.00
$4,999.00
2,013.83
2,685.33
3,356.83
2,759.68
3,679.88
4,600.08
363,298.86
484,438.86
605,578.86
198,873.89
265,187.29
331,500.69
Add To Cart Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report